Regeneron Earnings Top Estimates as Drug Sales Rise

Updated on

Regeneron Pharmaceuticals Inc., the maker of the eye treatment Eylea, reported first-quarter profit that topped analysts’ estimates as sales surged.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.